Discover published sets by community

Drug Class: Long-acting Beta-2 agonist; Mechanism: Activates beta-2 receptors leading to bronchial smooth muscle relaxation.

Drug Class: Methylxanthine; Mechanism: Inhibits phosphodiesterase, leading to increased cAMP and bronchodilation.

Drug Class: Methylxanthine; Mechanism: Increases intracellular cAMP by inhibiting phosphodiesterase, causing bronchodilation.

Drug Class: Long-acting Beta-2 agonist; Mechanism: Stimulates beta-2 adrenergic receptors, providing long-term relaxation of airway smooth muscle.

Drug Class: Ultra-long-acting Beta-2 agonist; Mechanism: Selectively stimulates beta-2 adrenergic receptors, providing sustained bronchodilation.

Drug Class: Short-acting Antimuscarinic; Mechanism: Blocks muscarinic cholinergic receptors, reducing bronchoconstriction.

Drug Class: Short-acting Beta-2 agonist; Mechanism: Stimulates beta-2 receptors to cause bronchodilation.

Drug Class: Short-acting Beta-2 agonist; Mechanism: Selectively stimulates beta-2 adrenergic receptors to promote bronchodilation.

Drug Class: Combination Long-acting Antimuscarinic and Long-acting Beta-2 agonist; Mechanism: Dual bronchodilation effect through muscarinic receptor blockade and beta-2 receptor stimulation.

Drug Class: Combination Corticosteroid and Long-acting Beta-2 agonist; Mechanism: Anti-inflammatory action and sustained bronchodilation.

Drug Class: Long-acting Beta-2 agonist; Mechanism: Binds to beta-2 receptors leading to bronchodilation over an extended period.

Drug Class: Combination Corticosteroid and Long-acting Beta-2 agonist; Mechanism: Anti-inflammatory action and bronchial smooth muscle relaxation.

Drug Class: Combination Corticosteroid and Long-acting Beta-2 agonist; Mechanism: Anti-inflammatory action and bronchodilation.

Drug Class: Short-acting Beta-2 agonist; Mechanism: Stimulates beta-2 adrenergic receptors, leading to relaxation of airway smooth muscle.